Alumis ALMS
NASDAQ ALMS
$7.77 -0.05 (-0.64%)
At close: Sep 18, 2026 · 4:00 PM EDT

Alumis (ALMS) Accounts Payables (2023 - 2026)

Alumis' (ALMS) quarterly Accounts Payables came in at $12.8 million in Q2 2026, down 14.56% year-over-year from $15.0 million in Q2 2025, and up 26.66% quarter-over-quarter from $10.1 million in Q4 2025.

Analysis

Alumis (ALMS) Accounts Payables (2023 - 2026) Analysis & Trends

Alumis (ALMS) has reported Accounts Payables for 4 consecutive years, with $12.8 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Accounts Payables fell 14.56% year-over-year to $12.8 million in Q2 2026; TTM through Jun 2026 was $12.8 million, a 14.56% decrease from a year earlier, with the FY2025 full-year figure at $10.1 million, up 5.01% from the prior year.
  • Accounts Payables was $12.8 million for Q2 2026 at Alumis, up from $10.1 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $15.0 million in Q2 2025 and troughed at $1.1 million in Q4 2023.
  • A 4-year average of $8.5 million and a median of $9.2 million in 2024 frame the typical range for Accounts Payables.
  • Across the five-year window, Accounts Payables soared 760.82% in 2024 and decreased 29.33% in 2025, its largest moves.
  • Over 4 years, Accounts Payables stood at $1.1 million in 2023, then soared by 760.82% to $9.6 million in 2024, then gained by 5.01% to $10.1 million in 2025, then grew by 26.66% to $12.8 million in 2026.
  • The last three Accounts Payables figures came in at $12.8 million (Q2 2026), $10.1 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 1.16 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 167.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 1.52 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 108.02 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 403.90 Mn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 25.08 Mn
10 Alumis 966.94 Mn 464.65 Mn - 12.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.80 Mn
Dec 31, 2025 10.11 Mn
Sep 30, 2025 4.55 Mn
Jun 30, 2025 14.98 Mn
Mar 31, 2025 7.47 Mn
Dec 31, 2024 9.62 Mn
Sep 30, 2024 6.44 Mn
Jun 30, 2024 9.19 Mn
Dec 31, 2023 1.12 Mn